Monday, February 20, 2017 10:47:22 AM
It's only recently that the FDA has been withholding approvals based on supply chain plant deficiencies.
It could be very possible that the 20mg and 40 mg suites run perfectly fine, but 10 rooms over there's a leak from a waterpipe that hasn't been fixed so the FDA will not give that plant any new business until it's satisfied the pipe is fixed.
I would doubt there's any problem with the manufacture of Glatopia, but rather there's something wrong in the plant.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM